다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Y mAbs Therapeutics Inc (YMAB)
Y mAbs Therapeutics Inc (YMAB) 뉴스

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:YMAB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	10:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/14	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/14	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/14	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/12	08:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/12	08:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/11	05:59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/11	05:44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/07	20:05	GlobeNewswire Inc.	Y-mAbs Announces Preclinical GD2-SADA Data to be Presented at 2024 SNMMI Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/05	20:05	GlobeNewswire Inc.	Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/01	21:15	GlobeNewswire Inc.	Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/01	21:05	GlobeNewswire Inc.	Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/01	10:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/01	10:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/05/24	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/05/22	05:42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/05/08	05:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/05/08	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/05/08	05:05	GlobeNewswire Inc.	Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/04/26	20:05	GlobeNewswire Inc.	Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/04/26	05:05	GlobeNewswire Inc.	Y-mAbs to Present at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/14	22:05	GlobeNewswire Inc.	Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/08	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/08	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/08	06:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/07	06:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/07	06:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/06	09:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/04	21:30	GlobeNewswire Inc.	Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/04	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc

검색 관련기사 보기:NASDAQ:YMAB

1 2 3 4 5 6 7 8 9 10 다음 >>

Financial Select Sector

Verizon Communications

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관